CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Properties & Pathways Acquires Logan Central Medical Centre for $12.19 Million

Jess Freeman • 09/06/2023

Logan-Central-Medical-Centre

Properties & Pathways has successfully acquired the Logan Central Medical Centre in Queensland from Centuria for $12.19 million, further strengthening Properties & Pathways' portfolio in the healthcare real estate sector.

Logan Central Medical Centre is a well-established medical facility situated on a prime 6,130sqm corner site at the intersection of Logan and Wembley Roads. With its central location and high visibility, the medical centre offers excellent accessibility to the local community.

The property features 10 single-level tenancies, encompassing a total Net Lettable Area (NLA) of 1,850sqm. The centre is anchored by ASX-listed Sonic Healthcare, including IPN Medical Centre, QLD X-Ray, and Sullivan Nicolaides Pathology. Furthermore, the facility provides ample parking with 44 car parks available for visitors and staff.

Mike Walsh and Peter Court of Cushman & Wakefield, along with Simon Quinn and Thomas Thorsen of JLL negotiated the sale on behalf of Centuria.

Mike Walsh, Director, Joint Head of Middle Markets, QLD at Cushman & Wakefield, commented on the evolving nature of healthcare real estate, which has become an attractive asset class for institutional investors.

“The non-cyclical income stream and increasing demand, driven by higher life expectancy and an ageing population in Australia, have made healthcare real estate an appealing investment. Furthermore, substantial government investments and the growth of the private health insurance sector have contributed to the expansion of healthcare expenditure in the country” he said.

The City of Logan LGA is projected to experience significant population growth in the coming years, particularly within the 65+ age group. This demographic trend is expected to be the main driver for increased demand in medical and healthcare services. Properties & Pathways recognizes this opportunity and is well-positioned to cater to the growing needs of the local community.

Peter Court, Director, Joint Head of Middle Markets, QLD at Cushman & Wakefield, said with the acquisition of Logan Central Medical Centre, Properties & Pathways reaffirms its commitment to investing in high-quality healthcare assets and providing exceptional medical facilities to communities across Australia.

“The company looks forward to delivering outstanding services and meeting the healthcare needs of Logan Central and its surrounding areas”.

How can we help?

Get in touch with one of our professionals.

RECENT NEWS

Andrew Fife and Ross Palframan_card.jpg
Cushman & Wakefield Wins WA Industrial Agent of the Year at Centuria Capital Group Awards

Cushman & Wakefield is proud to announce that Andrew Fife and Ross Palframan, from the firm’s Western Australia Industrial & Logistics team, have been awarded WA Industrial Agent of the Year by Centuria Capital Group.

Jess Freeman • 28/11/2025

219 St Georges Terrace.jpg
NRW Holdings secures landmark CBD lease at 219 St Georges Terrace

In a significant move for Perth’s commercial property market, NRW Holdings, the ASX-listed mining services powerhouse with a market cap of approximately $2.3 billion, has signed a 10-year lease for 7,950 sqm at 219 St Georges Terrace.

Jess Freeman • 26/11/2025

New Bond Street, London.jpg
London’s New Bond Street Named World’s Most Expensive Retail Destination For First Time

London’s New Bond Street, where rents have risen by 22% in the past year to USD $2,231 per square foot per year (psf/yr), has been crowned the world’s most expensive retail destination for the first time, according to Cushman & Wakefield (NYSE: CWK).

Jess Freeman • 19/11/2025

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Privacy & Cookies.
MORE OPTIONS
AGREE AND CLOSE
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS